Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 10, Issue 4, 1998, Pages 433-439

  Hirono, Nobutsugu ^a,b   Mori, Etsuro ^a   Ishii, Kazunari ^a   Kitagaki, Hajime ^a   Sasaki, Masahiro ^a   Ikejiri, Yoshitaka ^a   Imamura, Toru ^a   Shimomura, Tatsuo ^a   Ikeda, Manabu ^a   Yamashita, Hikari ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ALZHEIMER DISEASE; ARTICLE; COMPARATIVE STUDY; DELUSION; FEMALE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCIPITAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0031730229     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.10.4.433     Document Type: Article

References (34)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC, American Psychiatric Association, 1994
2. Wragg RE, Jeste DV: Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989; 146:577-587
3. Rubin EH: Psychosis in neurologic diseases: delusions as part of Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1992; 5:108-113
4. Cummings JL: Psychosis in neurologic disease: neurobiology and pathogenesis. Neuropsychiatry Neuropsychol Behav Neurol 1992; 5:144-150
5. Gustafson L, Risberg J: Regional cerebral blood flow related to psychiatric symptoms in dementia with onset in the presenile period. Acta Psychiatr Scand 1974; 50:516-538
6. Starkstein SE, Vázquez S, Petracca G, et al: A SPECT study of delusions in Alzheimer's disease. Neurology 1994; 44:2055-2059
7. Kotrla KJ, Chacko RC, Harper RG, et al: SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry 1995; 152:1470-1475
8. Pontón MO, Darcourt J, Miller BL, et al: Psychometric and SPECT studies in Alzheimer's disease with and without delusions. Neuropsychiatry Neuropsychol Behav Neurol 1995; 8:264-270
9. Grady CL, Haxby JV, Schapiro MB, et al: Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J Neuropsychiatry Clin Neurosci 1990; 2:373-384
10. Sultzer DL, Mahler ME, Mandelkern MA, et al: The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995; 7:476-484
11. Mentis MJ, Weinstein EA, Horwitz B, et al: Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer's disease. Biol Psychiatry 1995; 38:438-449
12. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944
13. Hughes CP, Berg L, Danziger WL, et al: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
14. Reisberg B, Borenstein J, Salob SP, et al: Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48(suppl 5):9-15
15. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
16. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
17. Ishii K, Sasaki M, Kitagaki H, et al: Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997; 38:925-928
18. Iida H, Miura S, Kanno I, et al: Design of evaluation of Headtome IV: a whole body positron emission tomograph. IEEE Trans Nucl Sci 1989; NS-37:1006-1010
19. Talairach J, Tournoux P: Co-planar stereotaxic atlas of the human brain. Stuttgart, Thieme Verlag, 1988
20. Phelps ME, Huang SC, Hoffman EJ, et al: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6:371-388
21. Paillère-Martinot ML, Dao-Castellana MH, Masure MC, et al: Delusional misidentification: a clinical, neuropsychological and brain imaging case study. Psychopathology 1994; 27:200-210
22. Lebert F, Pasquier F, Steinling M, et al: SPECT data in a case of secondary Capgras delusion. Psychopathology 1994; 27:211-214
23. Cummings JL, Miller B, Hill MA, et al: Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol 1987; 44:389-393
24. Devanand DP, Miller L, Richards M, et al: The Columbia University Scale for Psychopathology in Alzheimer's Disease. Arch Neurol 1992; 49:371-376
25. Lipowski ZJ: Delirium (acute confusional states). JAMA 1987; 258:1789-1792
26. Medina JL, Rubino FA, Ross E: Agitated delirium caused by infarctions of the hippocampal formation and fusiform and lingual gyri: a case report. Neurology 1974; 24:1181-1183
27. Devinsky O, Bear D, Volpe BT: Confusional states following posterior cerebral artery infarction. Arch Neurol 1988; 45:160-163
28. Milandre L, Brosset C, Botti G, et al: Étude de 82 infarctus du territoire des artères cérébrales postérieures [A study of 82 cases of posterior cerebral artery territory infarction]. Rev Neurol (Paris) 1994; 150:133-141
29. Nicolai A, Lazzarino LG: Acute confusional states secondary to infarctions in the territory of the posterior cerebral artery in elderly patients. Ital J Neurol Sci 1994; 15:91-96
30. DeLisi LE, Buchsbaum MS, Holcomb HH, et al: Increased temporal lobe glucose use in chronic schizophrenic patients. Biol Psychiatry 1989; 25:835-851
31. Liddle PF, Friston KJ, Frith CD, et al: Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992; 160:179-186
32. Kaplan RD, Szechtman H, Franco S, et al: Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography. Schizophr Res 1993; 11: 47-54
33. Cummings JL: Organic delusions: phenomenology, anatomical correlations, and review. Br J Psychiatry 1985; 146:184-197
34. Krieckhaus EE, Donahoe JW, Morgan MA: Paranoid schizophrenia may be caused by dopamine hyperactivity of CA1 hippocampus. Biol Psychiatry 1992; 31:560-570